Literature DB >> 10169297

The cost-effectiveness of a cardiovascular risk reduction program in general practice.

G Salkeld1, P Phongsavan, B Oldenburg, M Johannesson, P Convery, P Graham-Clarke, S Walker, J Shaw.   

Abstract

An economic evaluation was conducted alongside a randomised controlled trial of two lifestyle interventions and a routine care (control) group to assess the cost-effectiveness of a general practice-based lifestyle change program for patients with risk factors for cardiovascular disease. Routine care was the base case comparator because it represents 'current therapy' for cardiovascular disease (CVD). A 'no care' control group was not considered a clinically acceptable alternative to lifestyle interventions. The interventions consisted of an education guide and video for GPs to assess individual patient risk factors and plan a program for risk factor behavior change. Each patient received a risk factor assessment, education materials, a series of videos to watch on lifestyle behaviors and some patients received a self-help booklet. Eighty-two general practitioners were randomised from 75 general practices in Sydney's Western Metropolitan Region to (i) routine care (n = 25), (ii) video group (n = 29) or (iii) video + self help group (n = 28). GPs enrolled patients into the trial who met selection criteria for being at risk of CVD. There were 255 patients in the routine care (control) group, 270 in the video (intervention) group and 232 in the video + self help (intervention) group enrolled in the trial. Outcome measures included patient risk factor status: blood pressure, body mass index, cholesterol and smoking status at entry to trial and after 1 year. Changes in risk factors were used to estimate quality adjusted life years (QALYs) gained. One hundred and thirty patients in the routine care group, 199 in the video group and 155 in the video + self help group remained in the trial at the 12-month review and had complete data. The cost per QALY for males ranged from $AUD152,000 to 204,000. Further analysis suggests that a program targeted at 'high risk' males would cost approximately $30,000 per QALY. The lifestyle interventions had no significant effect on cardiovascular risk factors when compared to routine patient care. There remains insufficient evidence that lifestyle programs conducted in general practices are effective. Resources for general practice-based lifestyle programs may be better spent on high risk patients who are contemplating changes in risk factor behaviours.

Entities:  

Mesh:

Year:  1997        PMID: 10169297     DOI: 10.1016/s0168-8510(97)00015-8

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  13 in total

1.  A Review of Multiple Health Behavior Change Interventions for Primary Prevention.

Authors:  Judith J Prochaska; James O Prochaska
Journal:  Am J Lifestyle Med       Date:  2011-05

2.  Drug costs associated with non-adherence to cholesterol management guidelines for primary prevention of cardiovascular disease in an elderly population: the Rotterdam study.

Authors:  Pearl D Gumbs; W M Monique Verschuren; Aukje K Mantel-Teeuwisse; Ardine G de Wit; Albert Hofman; Paul H Trienekens; Bruno H Ch Stricker; Antonius de Boer; Olaf H Klungel
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 3.  Lifestyle interventions in primary care: systematic review of randomized controlled trials.

Authors:  Patrick Fleming; Marshall Godwin
Journal:  Can Fam Physician       Date:  2008-12       Impact factor: 3.275

Review 4.  Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases.

Authors:  Sanjib Saha; Ulf-G Gerdtham; Pia Johansson
Journal:  Int J Environ Res Public Health       Date:  2010-08-09       Impact factor: 3.390

5.  Cost-effectiveness of cardiovascular risk management by practice nurses in primary care.

Authors:  Ans H Tiessen; Karin M Vermeulen; Jan Broer; Andries J Smit; Klaas van der Meer
Journal:  BMC Public Health       Date:  2013-02-18       Impact factor: 3.295

6.  Changes in CVD risk factors in the activity counseling trial.

Authors:  Meghan Baruth; Sara Wilcox; James F Sallis; Abby C King; Bess H Marcus; Steven N Blair
Journal:  Int J Gen Med       Date:  2011-01-19

7.  The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model.

Authors:  Ella Zomer; Alice Owen; Dianna J Magliano; Danny Liew; Christopher M Reid
Journal:  BMJ       Date:  2012-05-30

Review 8.  Strategies to improve smoking cessation rates in primary care.

Authors:  Nicola Lindson; Gillian Pritchard; Bosun Hong; Thomas R Fanshawe; Andrew Pipe; Sophia Papadakis
Journal:  Cochrane Database Syst Rev       Date:  2021-09-06

9.  Training practitioners to deliver opportunistic multiple behaviour change counselling in primary care: a cluster randomised trial.

Authors:  Christopher C Butler; Sharon A Simpson; Kerenza Hood; David Cohen; Tim Pickles; Clio Spanou; Jim McCambridge; Laurence Moore; Elizabeth Randell; M Fasihul Alam; Paul Kinnersley; Adrian Edwards; Christine Smith; Stephen Rollnick
Journal:  BMJ       Date:  2013-03-19

10.  An economic model of long-term use of celecoxib in patients with osteoarthritis.

Authors:  Michael Loyd; Dale Rublee; Philip Jacobs
Journal:  BMC Gastroenterol       Date:  2007-07-04       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.